BRM/BRG1 ATP-IN-8, CAS [[2468046-72-0]] Preis auf Anfrage
Biozol Catalog Number:
MCE-HY-178490
Supplier Catalog Number:
HY-178490
Alternative Catalog Number:
MCE-HY-178490-1UNIT
Manufacturer:
MedchemExpress
Category:
Biochemikalien
BRM/BRG1 ATP-IN-8 (Compound Cpd14) is an orally active BRG1/BRM ATPase domain inhibitor. BRM/BRG1 ATP-IN-8 exerts antitumor effects by disrupting aberrant chromatin remodeling in cancer cells, inducing apoptosis and growth arrest. BRM/BRG1 ATP-IN-8 is promising for research of BRG1/BRM-dependent malignancies, including hematological cancers, prostate cancer, breast cancer, and Ewings sarcoma[1].
Molecular Weight:
565.62
CAS Number:
[2468046-72-0]
Formula:
C26H23N5O6S2
Target:
Epigenetic Reader Domain
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted